Drug Shortage Report for RAN-GABAPENTIN
Report ID | 1546 |
Drug Identification Number | 02319063 |
Brand name | RAN-GABAPENTIN |
Common or Proper name | RAN™-GABAPENTIN |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-02-01 |
Actual start date | 2017-02-01 |
Estimated end date | 2018-09-24 |
Actual end date | 2018-09-12 |
Shortage status | Resolved |
Updated date | 2019-02-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2019-02-01 | French | Compare |
v13 | 2019-02-01 | English | Compare |
v12 | 2018-08-21 | French | Compare |
v11 | 2018-08-21 | English | Compare |
v10 | 2017-11-22 | French | Compare |
v9 | 2017-11-22 | English | Compare |
v8 | 2017-09-26 | French | Compare |
v7 | 2017-09-26 | English | Compare |
v6 | 2017-09-12 | French | Compare |
v5 | 2017-09-12 | English | Compare |
v4 | 2017-04-12 | French | Compare |
v3 | 2017-04-12 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 14 of 14